Prudential Financial’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-56,235
Closed -$2.32M 2309
2015
Q2
$2.32M Buy
56,235
+700
+1% +$25.1K ﹤0.01% 1500
2015
Q1
$1.96M Buy
55,535
+970
+2% +$32.8K ﹤0.01% 1599
2014
Q4
$1.75M Sell
54,565
-600
-1% -$17.4K ﹤0.01% 1529
2014
Q3
$1.55M Sell
55,165
-3,921
-7% -$119K ﹤0.01% 1554
2014
Q2
$1.79M Sell
59,086
-25,879
-30% -$714K ﹤0.01% 1574
2014
Q1
$2.35M Sell
84,965
-14,200
-14% -$372K ﹤0.01% 1377
2013
Q4
$2.53M Sell
99,165
-28,500
-22% -$878K 0.01% 1322
2013
Q3
$3.81M Sell
127,665
-87,772
-41% -$2.44M 0.01% 1066
2013
Q2
$6.19M Buy
+215,437
New +$5.94M 0.01% 816

Other funds holding BRLI

Prudential Financial's BRLI Position: Q3 2015 in Review

Prudential Financial sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 56,235 shares — an estimated $2.32M sold.

Prudential Financial first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $6.19M in Q2 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Prudential Financial reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Prudential Financial sold 56,235 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.32M.
  • Prudential Financial first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Prudential Financial's BIO-REFERENCE LABS INC-NEW- position peaked at $6.19M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Prudential Financial's 13F filing for Q3 2015, filed 10 Nov 2015.